This report aims to provide a comprehensive presentation of the global market for Vaccine Adjuvants, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Adjuvants.

The Vaccine Adjuvants market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Vaccine Adjuvants market size in 2022 is 813.33 million US dollars, and it is expected to be 1761.26 million US dollars by 2029, with a compound annual growth rate of 11.67% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Vaccine Adjuvants market include GlaxoSmithKline Plc, Moderna Inc., Sanofi Pasteur, Adjuvatis, and Avanti Polar Lipids, Inc.. The share of the top 3 players in the Vaccine Adjuvants market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Vaccine Adjuvants market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Mineral Salt-based Adjuvant accounted for XX% of Vaccine Adjuvants market in 2022. Tensoactive Adjuvants share of XX%.
Infectious Diseases accounted for XX% of the Vaccine Adjuvants market in 2022. Rare Diseases accounts for XX%.

Highlights-Regions

Americas
United States
Canada
Brazil
Argentina
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
MEA
Saudi Arabia
UAE
Turkey

Player list
GlaxoSmithKline Plc
Moderna Inc.
Sanofi Pasteur
Adjuvatis
Avanti Polar Lipids, Inc.
SPI Pharma
MPV Technologies
Novavax, Inc.
Statens Serum Institut
CSL Limited
Viscogel AB
VaxLiant LLC
Aphios Corporation
Vaxine Pty Ltd
CureVac AG
Sergeant Adjuvants
Agenus, Inc.
OZ Biosciences
Adjuvants Unlimited Inc.
Adjuvants Euclid Canada Inc.

Types list
Mineral Salt-based Adjuvant
Tensoactive Adjuvants
Adjuvant Emulsions
Liposome Adjuvants
Carbohydrate Adjuvants
Bacteria-derived Adjuvants
Virus-like Particles (VLP)
Other Types

Application list
Infectious Diseases
Rare Diseases
Cancer
Autoimmune Disorders
Others

Table of Content

1 Study Coverage
1.1 Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global Vaccine Adjuvants Market by Region
1.4.1 Global Vaccine Adjuvants Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global Vaccine Adjuvants Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Vaccine Adjuvants Revenue by Players
2.1.1 Global Vaccine Adjuvants Revenue by Players (2018-2023)
2.1.2 Global Vaccine Adjuvants Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by Vaccine Adjuvants Revenue in 2023
2.2 Global Vaccine Adjuvants Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Vaccine Adjuvants Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 GlaxoSmithKline Plc
3.1.1 GlaxoSmithKline Plc Information
3.1.2 GlaxoSmithKline Plc Overview
3.1.3 GlaxoSmithKline Plc Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.1.4 GlaxoSmithKline Plc Related Developments
3.2 Moderna Inc.
3.2.1 Moderna Inc. Information
3.2.2 Moderna Inc. Overview
3.2.3 Moderna Inc. Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.2.4 Moderna Inc. Related Developments
3.3 Sanofi Pasteur
3.3.1 Sanofi Pasteur Information
3.3.2 Sanofi Pasteur Overview
3.3.3 Sanofi Pasteur Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.3.4 Sanofi Pasteur Related Developments
3.4 Adjuvatis
3.4.1 Adjuvatis Information
3.4.2 Adjuvatis Overview
3.4.3 Adjuvatis Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.4.4 Adjuvatis Related Developments
3.5 Avanti Polar Lipids, Inc.
3.5.1 Avanti Polar Lipids, Inc. Information
3.5.2 Avanti Polar Lipids, Inc. Overview
3.5.3 Avanti Polar Lipids, Inc. Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.5.4 Avanti Polar Lipids, Inc. Related Developments
3.6 SPI Pharma
3.6.1 SPI Pharma Information
3.6.2 SPI Pharma Overview
3.6.3 SPI Pharma Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.6.4 SPI Pharma Related Developments
3.7 MPV Technologies
3.7.1 MPV Technologies Information
3.7.2 MPV Technologies Overview
3.7.3 MPV Technologies Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.7.4 MPV Technologies Related Developments
3.8 Novavax, Inc.
3.8.1 Novavax, Inc. Information
3.8.2 Novavax, Inc. Overview
3.8.3 Novavax, Inc. Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.8.4 Novavax, Inc. Related Developments
3.9 Statens Serum Institut
3.9.1 Statens Serum Institut Information
3.9.2 Statens Serum Institut Overview
3.9.3 Statens Serum Institut Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.9.4 Statens Serum Institut Related Developments
3.10 CSL Limited
3.10.1 CSL Limited Information
3.10.2 CSL Limited Overview
3.10.3 CSL Limited Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.10.4 CSL Limited Related Developments
3.11 Viscogel AB
3.11.1 Viscogel AB Information
3.11.2 Viscogel AB Overview
3.11.3 Viscogel AB Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.11.4 Viscogel AB Related Developments
3.12 VaxLiant LLC
3.12.1 VaxLiant LLC Information
3.12.2 VaxLiant LLC Overview
3.12.3 VaxLiant LLC Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.12.4 VaxLiant LLC Related Developments
3.13 Aphios Corporation
3.13.1 Aphios Corporation Information
3.13.2 Aphios Corporation Overview
3.13.3 Aphios Corporation Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.13.4 Aphios Corporation Related Developments
3.14 Vaxine Pty Ltd
3.14.1 Vaxine Pty Ltd Information
3.14.2 Vaxine Pty Ltd Overview
3.14.3 Vaxine Pty Ltd Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.14.4 Vaxine Pty Ltd Related Developments
3.15 CureVac AG
3.15.1 CureVac AG Information
3.15.2 CureVac AG Overview
3.15.3 CureVac AG Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.15.4 CureVac AG Related Developments
3.16 Sergeant Adjuvants
3.16.1 Sergeant Adjuvants Information
3.16.2 Sergeant Adjuvants Overview
3.16.3 Sergeant Adjuvants Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.16.4 Sergeant Adjuvants Related Developments
3.17 Agenus, Inc.
3.17.1 Agenus, Inc. Information
3.17.2 Agenus, Inc. Overview
3.17.3 Agenus, Inc. Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.17.4 Agenus, Inc. Related Developments
3.18 OZ Biosciences
3.18.1 OZ Biosciences Information
3.18.2 OZ Biosciences Overview
3.18.3 OZ Biosciences Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.18.4 OZ Biosciences Related Developments
3.19 Adjuvants Unlimited Inc.
3.19.1 Adjuvants Unlimited Inc. Information
3.19.2 Adjuvants Unlimited Inc. Overview
3.19.3 Adjuvants Unlimited Inc. Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.19.4 Adjuvants Unlimited Inc. Related Developments
3.20 Adjuvants Euclid Canada Inc.
3.20.1 Adjuvants Euclid Canada Inc. Information
3.20.2 Adjuvants Euclid Canada Inc. Overview
3.20.3 Adjuvants Euclid Canada Inc. Vaccine Adjuvants Revenue and Gross Margin (2018-2023)
3.20.4 Adjuvants Euclid Canada Inc. Related Developments
4 Market Size by Type
4.1 Global Vaccine Adjuvants Revenue by Type
4.2 Global Vaccine Adjuvants Market Size Growth by Type 2018-2023
5 Market Size by Application
5.1 Global Vaccine Adjuvants Revenue by Application
5.2 Global Vaccine Adjuvants Market Size Growth by Application 2018-2023
6 Global Vaccine Adjuvants Market Insights
6.1 Global Vaccine Adjuvants Market Revenue 2018-2023
6.2 Global Vaccine Adjuvants Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Vaccine Adjuvants Market Size by Country
7.1.1 Americas Vaccine Adjuvants Revenue by Country (2018-2023)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Vaccine Adjuvants Market Size by Country
8.1.1 Europe Vaccine Adjuvants Revenue by Country (2018-2023)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Vaccine Adjuvants Market Size by Region
9.1.1 Asia Pacific Vaccine Adjuvants Revenue by Region (2018-2023)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Vaccine Adjuvants Market Size by Country
10.1.1 Middle East and Africa Vaccine Adjuvants Revenue by Country (2018-2023)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Vaccine Adjuvants Industry Trends
11.2 Vaccine Adjuvants Market Drivers
11.3 Vaccine Adjuvants Market Challenges
11.4 Vaccine Adjuvants Market Restraints
12 Vaccine Adjuvants Forecasted Market Size by Type
12.1 Global Vaccine Adjuvants Forecasted Revenue by Type
12.2 Global Vaccine Adjuvants Forecasted Market Size Growth by Type 2023-2029
13 Vaccine Adjuvants Forecasted Market Size by Application
13.1 Global Vaccine Adjuvants Forecasted Revenue by Application
13.2 Global Vaccine Adjuvants Forecasted Market Size Growth by Application 2023-2029
14 Global Vaccine Adjuvants Market Forecasts
14.1 Global Vaccine Adjuvants Market Revenue Forecasts 2023-2029
14.2 Global Vaccine Adjuvants Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Vaccine Adjuvants Forecasts Revenue by Country (2018-2023)
14.4 Europe
14.4.1 Europe Vaccine Adjuvants Forecasts Revenue by Country (2018-2023)
14.5 Asia-Pacific
14.5.1 Asia Pacific Vaccine Adjuvants Forecasts Revenue by Country (2018-2023)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Vaccine Adjuvants Forecasts Revenue by Country (2018-2023)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer

List of Tables and Figures

Figure Vaccine Adjuvants Picture
Table Product Definition of Vaccine Adjuvants
Table Global Vaccine Adjuvants Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
Table Global Vaccine Adjuvants Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
Table Global Vaccine Adjuvants Market by Region: 2018 VS 2023 VS 2029
Figure Global Vaccine Adjuvants Revenue Market Size & Forecasts 2018-2029
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Vaccine Adjuvants Revenue by Players (2018-2023)
Table Global Vaccine Adjuvants Revenue Market Share by Players (2018-2023)
Figure Top 5 Largest Players of Vaccine Adjuvants in 2023
Figure Top 10 Largest Players of Vaccine Adjuvants in 2023
Table Global Vaccine Adjuvants Gross Margin by Players
Table Players Market Concentration Ratio (CR5)
Table Global Vaccine Adjuvants Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table GlaxoSmithKline Plc Overview
Table GlaxoSmithKline Plc Revenue, Gross, Gross Margin 2018-2023
Table GlaxoSmithKline Plc Related Developments
Table Company Profiles
Table Moderna Inc. Overview
Table Moderna Inc. Revenue, Gross, Gross Margin 2018-2023
Table Moderna Inc. Related Developments
Table Company Profiles
Table Sanofi Pasteur Overview
Table Sanofi Pasteur Revenue, Gross, Gross Margin 2018-2023
Table Sanofi Pasteur Related Developments
Table Company Profiles
Table Adjuvatis Overview
Table Adjuvatis Revenue, Gross, Gross Margin 2018-2023
Table Adjuvatis Related Developments
Table Company Profiles
Table Avanti Polar Lipids, Inc. Overview
Table Avanti Polar Lipids, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Avanti Polar Lipids, Inc. Related Developments
Table Company Profiles
Table SPI Pharma Overview
Table SPI Pharma Revenue, Gross, Gross Margin 2018-2023
Table SPI Pharma Related Developments
Table Company Profiles
Table MPV Technologies Overview
Table MPV Technologies Revenue, Gross, Gross Margin 2018-2023
Table MPV Technologies Related Developments
Table Company Profiles
Table Novavax, Inc. Overview
Table Novavax, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Novavax, Inc. Related Developments
Table Company Profiles
Table Statens Serum Institut Overview
Table Statens Serum Institut Revenue, Gross, Gross Margin 2018-2023
Table Statens Serum Institut Related Developments
Table Company Profiles
Table CSL Limited Overview
Table CSL Limited Revenue, Gross, Gross Margin 2018-2023
Table CSL Limited Related Developments
Table Company Profiles
Table Viscogel AB Overview
Table Viscogel AB Revenue, Gross, Gross Margin 2018-2023
Table Viscogel AB Related Developments
Table Company Profiles
Table VaxLiant LLC Overview
Table VaxLiant LLC Revenue, Gross, Gross Margin 2018-2023
Table VaxLiant LLC Related Developments
Table Company Profiles
Table Aphios Corporation Overview
Table Aphios Corporation Revenue, Gross, Gross Margin 2018-2023
Table Aphios Corporation Related Developments
Table Company Profiles
Table Vaxine Pty Ltd Overview
Table Vaxine Pty Ltd Revenue, Gross, Gross Margin 2018-2023
Table Vaxine Pty Ltd Related Developments
Table Company Profiles
Table CureVac AG Overview
Table CureVac AG Revenue, Gross, Gross Margin 2018-2023
Table CureVac AG Related Developments
Table Company Profiles
Table Sergeant Adjuvants Overview
Table Sergeant Adjuvants Revenue, Gross, Gross Margin 2018-2023
Table Sergeant Adjuvants Related Developments
Table Company Profiles
Table Agenus, Inc. Overview
Table Agenus, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Agenus, Inc. Related Developments
Table Company Profiles
Table OZ Biosciences Overview
Table OZ Biosciences Revenue, Gross, Gross Margin 2018-2023
Table OZ Biosciences Related Developments
Table Company Profiles
Table Adjuvants Unlimited Inc. Overview
Table Adjuvants Unlimited Inc. Revenue, Gross, Gross Margin 2018-2023
Table Adjuvants Unlimited Inc. Related Developments
Table Company Profiles
Table Adjuvants Euclid Canada Inc. Overview
Table Adjuvants Euclid Canada Inc. Revenue, Gross, Gross Margin 2018-2023
Table Adjuvants Euclid Canada Inc. Related Developments
Table Global Vaccine Adjuvants Revenue by Type (2018-2023)
Table Global Vaccine Adjuvants Revenue Share by Type (2018-2023)
Table Global Vaccine Adjuvants Revenue by Application (2018-2023)
Table Global Vaccine Adjuvants Revenue Share by Application (2018-2023)
Figure Global Vaccine Adjuvants Market Revenue 2018-2023
Table Global Vaccine Adjuvants Revenue by Region (2018-2023)
Table Global Vaccine Adjuvants Revenue Share by Region (2018-2023)
Figure Americas Vaccine Adjuvants Revenue (2018-2023)
Figure Europe Vaccine Adjuvants Revenue (2018-2023)
Figure Asia-Pacific Vaccine Adjuvants Revenue (2018-2023)
Figure Middle East & Africa Vaccine Adjuvants Revenue (2018-2023)
Table Americas Vaccine Adjuvants Revenue by Country (2018-2023)
Table Americas Vaccine Adjuvants Revenue Share by Country (2018-2023)
Figure United States Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure Canada Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure Mexico Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure Brazil Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure Argentina Vaccine Adjuvants Revenue Market Size (2018-2023)
Table Europe Vaccine Adjuvants Revenue by Country (2018-2023)
Table Europe Vaccine Adjuvants Revenue Share by Country (2018-2023)
Figure Germany Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure France Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure U.K. Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure Italy Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure Russia Vaccine Adjuvants Revenue Market Size (2018-2023)
Table Asia Pacific Vaccine Adjuvants Revenue by Region (2018-2023)
Table Asia Pacific Vaccine Adjuvants Revenue Share by Region (2018-2023)
Figure China Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure Japan Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure South Korea Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure India Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure Southeast Asia Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure Australia Vaccine Adjuvants Revenue Market Size (2018-2023)
Table Middle East and Africa Vaccine Adjuvants Revenue by Country (2018-2023)
Table Middle East and Africa Vaccine Adjuvants Revenue Share by Country (2018-2023)
Figure Turkey Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure Saudi Arabia Vaccine Adjuvants Revenue Market Size (2018-2023)
Figure U.A.E Vaccine Adjuvants Revenue Market Size (2018-2023)
Table Global Vaccine Adjuvants Forecasted Revenue by Type (2018-2023)
Table Global Vaccine Adjuvants Forecasted Revenue Share by Type (2018-2023)
Table Global Vaccine Adjuvants Forecasted Revenue by Application (2018-2023)
Table Global Vaccine Adjuvants Forecasted Revenue Share by Application (2018-2023)
Figure Global Vaccine Adjuvants Market Revenue Forecasts 2023-2029
Table Global Vaccine Adjuvants Forecasts Revenue by Region (2023-2029)
Table Global Vaccine Adjuvants Forecasts Revenue Share by Region (2023-2029)
Figure Americas Vaccine Adjuvants Forecasts Revenue and Growth (2023-2029)
Table Americas Vaccine Adjuvants Forecasts Revenue by Country (2018-2023)
Table Americas Vaccine Adjuvants Forecasts Revenue Share by Country (2018-2023)
Figure Europe Vaccine Adjuvants Forecasts Revenue and Growth (2023-2029)
Table Europe Vaccine Adjuvants Forecasts Revenue by Country (2018-2023)
Table Europe Vaccine Adjuvants Forecasts Revenue Share by Country (2018-2023)
Figure Asia-Pacific Vaccine Adjuvants Forecasts Revenue and Growth (2023-2029)
Table Asia Pacific Vaccine Adjuvants Forecasts Revenue by Country (2018-2023)
Table Asia Pacific Vaccine Adjuvants Forecasts Revenue Share by Country (2018-2023)
Figure Middle East & Africa Vaccine Adjuvants Forecasts Revenue and Growth (2023-2029)
Table Middle East and Africa Vaccine Adjuvants Forecasts Revenue by Country (2018-2023)
Table Middle East and Africa Vaccine Adjuvants Forecasts Revenue Share by Country (2018-2023)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report